Gov. Glenn Youngkin announced Monday that pharmaceutical giant AstraZeneca will build its largest single manufacturing facility in Virginia as part of a $50 billion investment in U.S. operations.
The project is expected to create hundreds of high-skilled jobs and will focus on producing respiratory and oncology medicines using artificial intelligence, automation and advanced data analytics.
“This project will set the standard for the latest technological advancements in pharmaceutical manufacturing, creating hundreds of highly skilled jobs and helping further strengthen the nation’s domestic supply chain,” Youngkin said in a statement. “Advanced manufacturing is at the heart of Virginia’s dynamic economy, so I am thrilled that AstraZeneca, one of the world’s leading pharmaceutical companies, plans to build a world-class pharmaceutical facility here in the Commonwealth.”
President Donald Trump referenced the announcement the following day in Oval Office remarks, framing AstraZeneca’s overall $50 billion investment as a response to U.S. trade policy and the political climate.
“AstraZeneca… is going to spend $50 billion… to build various places all over the country, big manufacturing plants, pharmaceutical plants,” Trump said Tuesday. “He said they did that because of the election and because of the fact that the tariffs are placed.”
Click this link for the original source of this article.
Author: Ray Hilbrich
This content is courtesy of, and owned and copyrighted by, https://www.offthepress.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.
